Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two sitagliptin + metformin fixed-dose combination tablets under fed conditions in healthy Thai volunteers
TCTR20200605001Phase 1Not yet recruiting
- Sponsor
- Novartis
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sitagliptin + metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novartis. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
sitagliptin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20200605001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200605001.